- Home
- Publications
- Publication Search
- Publication Details
Title
A Critical Role for the mTORC2 Pathway in Lung Fibrosis
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 8, Pages e106155
Publisher
Public Library of Science (PLoS)
Online
2014-08-28
DOI
10.1371/journal.pone.0106155
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- mTORC1/C2 and pan-HDAC inhibitors synergistically impair breast cancer growth by convergent AKT and polysome inhibiting mechanisms
- (2014) Kathleen A. Wilson-Edell et al. BREAST CANCER RESEARCH AND TREATMENT
- A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
- (2014) Talmadge E. King et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
- (2014) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Translational Landscape of the Mammalian Cell Cycle
- (2013) Craig R. Stumpf et al. MOLECULAR CELL
- Bleomycin Induces Molecular Changes Directly Relevant to Idiopathic Pulmonary Fibrosis: A Model for “Active” Disease
- (2013) Ruoqi Peng et al. PLoS One
- MiR-424/503-Mediated Rictor Upregulation Promotes Tumor Progression
- (2013) Chitose Oneyama et al. PLoS One
- Keloid Disease Can Be Inhibited by Antagonizing Excessive mTOR Signaling With a Novel Dual TORC1/2 Inhibitor
- (2012) Farhatullah Syed et al. AMERICAN JOURNAL OF PATHOLOGY
- Investigational drug MLN0128, a novel TORC1/2 inhibitor, demonstrates potent oral antitumor activity in human breast cancer xenograft models
- (2012) Yesim Gökmen-Polar et al. BREAST CANCER RESEARCH AND TREATMENT
- Efficacy of the investigational mTOR kinase inhibitor MLN0128/INK128 in models of B-cell acute lymphoblastic leukemia
- (2012) M R Janes et al. LEUKEMIA
- PRR5L degradation promotes mTORC2-mediated PKC-δ phosphorylation and cell migration downstream of Gα12
- (2012) Xiaoqing Gan et al. NATURE CELL BIOLOGY
- Role of the integrin-linked kinase (ILK)/Rictor complex in TGFβ-1-induced epithelial–mesenchymal transition (EMT)
- (2012) I Serrano et al. ONCOGENE
- Sirolimus-Induced Pneumonitis After Renal Transplantation: A Single-Center Experience
- (2012) H.S. Lee et al. TRANSPLANTATION PROCEEDINGS
- mTOR complex 2 signaling and functions
- (2011) Won Jun Oh et al. CELL CYCLE
- An investigator-driven study of everolimus in surgical lung biopsy confirmed idiopathic pulmonary fibrosis
- (2011) MONIQUE A. MALOUF et al. RESPIROLOGY
- Pathologic Caveolin-1 Regulation of PTEN in Idiopathic Pulmonary Fibrosis
- (2010) Hong Xia et al. AMERICAN JOURNAL OF PATHOLOGY
- Inhibition and Role of let-7d in Idiopathic Pulmonary Fibrosis
- (2010) Kusum V. Pandit et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Emergent toxicities associated with the use of mTOR inhibitors in patients with advanced renal carcinoma
- (2010) Jesus Rodriguez-Pascual et al. ANTI-CANCER DRUGS
- FoxOs Inhibit mTORC1 and Activate Akt by Inducing the Expression of Sestrin3 and Rictor
- (2010) Chia-Chen Chen et al. DEVELOPMENTAL CELL
- SPARC Suppresses Apoptosis of Idiopathic Pulmonary Fibrosis Fibroblasts through Constitutive Activation of β-Catenin
- (2010) Wenteh Chang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor
- (2010) Matthew R Janes et al. NATURE MEDICINE
- Akt-RSK-S6 Kinase Signaling Networks Activated by Oncogenic Receptor Tyrosine Kinases
- (2010) A. Moritz et al. Science Signaling
- mTORC1 signalling and mRNA translation: Figure 1
- (2009) Christopher G. Proud BIOCHEMICAL SOCIETY TRANSACTIONS
- Mammalian Target of Rapamycin: Discovery of Rapamycin Reveals a Signaling Pathway Important for Normal and Cancer Cell Growth
- (2009) James J. Gibbons et al. SEMINARS IN ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started